课题基金 / 基金详情

Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder

Gene Expression Signature Technology to Repurpose Drugs for Bipolar Disorder
基因表达特征技术重新利用治疗双相情感障碍的药物
批准号:
nhmrc : 1078928
负责人:
Prof Brian Dean
金额:
$32.19万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

Prof Brian Dean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project we will generate a Gene Expression Signature that best characterises the overall biological effects of a cocktail of drugs currently used to treat bipolar disorder. The Signature will be identified in cells and intact brains, and then validated using human gene expression profiling. The validated Signature will then be used to screen libraries and discover new drugs for treating bipolar disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the pathophysiology of schizophrenia, major depressive disorder and bipolar disorder as a basis for improving treatments
  • 批准号:
    nhmrc : 1002240
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $53.62万
  • 财政年份:
    2011
  • 负责人:
    Prof Brian Dean
  • 依托单位:
Understanding the Role of Muscarinic Receptors in the Pathophysiology of Depression and Bipolar Disorder
  • 批准号:
    nhmrc : 628669
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $32.01万
  • 财政年份:
    2010
  • 负责人:
    Prof Brian Dean
  • 依托单位:
Research Fellowship - Grant ID:400016
  • 批准号:
    nhmrc : 400016
  • 项目类别:
    NHMRC Research Fellowships
  • 资助金额:
    $40.48万
  • 财政年份:
    2006
  • 负责人:
    Prof Brian Dean
  • 依托单位:
A Study of Muscarinic Receptors in Brain Tissue Obtained Postmortem from Subjects with Schizophrenia
  • 批准号:
    nhmrc : 209046
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $23.66万
  • 财政年份:
    2002
  • 负责人:
    Prof Brian Dean
  • 依托单位:
国内基金
海外基金
HarpinXoo 启动水稻抗病性及相关信号传导调控基因的表达图式 (expression profiles)
  • 批准号:
    30370969
  • 项目类别:
    面上项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2003
  • 负责人:
    董汉松
  • 依托单位: